ZVSA
ZyVersa Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.05
+0.00%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- May 13, 2026
- EPS actual
- -$0.22
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +25.8%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 13, 2026 | — | -$0.22 | — | — |
| Mar 31, 2026 | -$0.30 | -$0.43 | Miss -43.33% | — |
| Nov 19, 2025 | — | -$0.15 | — | — |
| Aug 13, 2025 | — | -$0.46 | — | — |
| Mar 31, 2025 | -$2.73 | -$1.31 | Beat 52.02% | $26.1K |
| Nov 14, 2024 | -$5.80 | -$2.43 | Beat 58.10% | — |
| Aug 9, 2024 | -$5.20 | -$3.31 | Beat 36.35% | — |
| May 15, 2024 | -$3.70 | -$4.53 | Miss -22.43% | — |
| Nov 14, 2023 | -$56 | -$31 | Beat 43.74% | — |
| Aug 21, 2023 | — | -$1.5K | — | — |
| May 12, 2023 | — | -$0.39 | — | — |
| Mar 31, 2023 | — | -$185 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026